Tafazzoli, Ali Chavan, Ameya Harty, Gerard Moller, Jorgen Wong, Schiffon L. Efficiency Model of Cladribine Tablets versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple Sclerosis <p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> © The authors, CC-BY-NC 2020.<b></b> Cladribine tablets;Disease-modifying drug;Efficiency model;Infusion;Relapsing-remitting multiple sclerosis 2020-07-07
    https://adisjournals.figshare.com/articles/figure/Efficiency_Model_of_Cladribine_Tablets_versus_Infusion-Based_Disease-Modifying_Drugs_for_Patients_with_Relapsing-Remitting_Multiple_Sclerosis/12562604
10.6084/m9.figshare.12562604.v1